BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 10386248)

  • 1. Role of dopamine in the pathogenesis of hypertension.
    Jose PA; Eisner GM; Felder RA
    Clin Exp Pharmacol Physiol Suppl; 1999 Apr; 26():S10-3. PubMed ID: 10386248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The peripheral dopaminergic system: morphological analysis, functional and clinical applications.
    Amenta F; Ricci A; Tayebati SK; Zaccheo D
    Ital J Anat Embryol; 2002; 107(3):145-67. PubMed ID: 12437142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dopaminergic system in hypertension.
    Zeng C; Zhang M; Asico LD; Eisner GM; Jose PA
    Clin Sci (Lond); 2007 Jun; 112(12):583-97. PubMed ID: 17492945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D1 dopamine receptor signalling defect in spontaneous hypertension.
    Felder RA; Eisner GM; Jose PA
    Acta Physiol Scand; 2000 Jan; 168(1):245-50. PubMed ID: 10691808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine receptors in hypertension.
    Bek MJ; Eisner GM; Felder RA; Jose PA
    Mt Sinai J Med; 2001 Nov; 68(6):362-9. PubMed ID: 11687863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dopamine receptor subtypes].
    Janković SM; Milovanović D; Mitrović M; Dukić-Dejanović S
    Med Pregl; 1996; 49(7-8):281-5. PubMed ID: 8926944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of selective dopamine receptor subtype agonists on cardiac contractility and regional haemodynamics in rats.
    Polakowski JS; Segreti JA; Cox BF; Hsieh GC; Kolasa T; Moreland RB; Brioni JD
    Clin Exp Pharmacol Physiol; 2004 Dec; 31(12):837-41. PubMed ID: 15659045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recent findings regarding physiological characteristics and effects of renal dopamine].
    Cuk M; Cuk D; Dvornik S; Mamula O; Manestar MM
    Lijec Vjesn; 2004; 126(5-6):147-55. PubMed ID: 15628684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The brain dopaminergic systems: receptor heterogeneity, functional role and pharmacological regulation].
    Raevskiĭ KS; Sotnikova TD; Gaĭnetdinov RR
    Usp Fiziol Nauk; 1996; 27(4):3-29. PubMed ID: 9019922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine receptor regulation of Ca2+ levels in individual isolated nerve terminals from rat striatum: comparison of presynaptic D1-like and D2-like receptors.
    Wu J; Dougherty JJ; Nichols RA
    J Neurochem; 2006 Jul; 98(2):481-94. PubMed ID: 16805841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine receptor-mediated regulation of RGS2 and RGS4 mRNA differentially depends on ascending dopamine projections and time.
    Taymans JM; Kia HK; Claes R; Cruz C; Leysen J; Langlois X
    Eur J Neurosci; 2004 Apr; 19(8):2249-60. PubMed ID: 15090051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of blood pressure by dopamine receptors.
    Jose PA; Eisner GM; Felder RA
    Nephron Physiol; 2003; 95(2):p19-27. PubMed ID: 14610323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal dopamine receptors in health and hypertension.
    Jose PA; Eisner GM; Felder RA
    Pharmacol Ther; 1998 Nov; 80(2):149-82. PubMed ID: 9839770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation by group I mGLU receptor activation and group III mGLU receptor blockade of locomotor responses induced by D1-like and D2-like receptor agonists in the nucleus accumbens.
    Rouillon C; Degoulet M; Chevallier K; Abraini JH; David HN
    Brain Res; 2008 Mar; 1198():44-54. PubMed ID: 18261716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic receptors: a new antihypertensive mechanism.
    Velasco M; Contreras F; Cabezas GA; Bolívar A; Fouillioux C; Hernández R
    J Hypertens Suppl; 2002 Jun; 20(3):S55-8. PubMed ID: 12184056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dopaminergic system in hypertension.
    Amenta F; Ricci A; Rossodivita I; Avola R; Tayebati SK
    Clin Exp Hypertens; 2001; 23(1-2):15-24. PubMed ID: 11270582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent aspect of the role of peripheral dopamine and its receptors in the pathogenesis of hypertension.
    Shigetomi S; Fukuchi S
    Fukushima J Med Sci; 1994 Dec; 40(2):69-83. PubMed ID: 7642168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The renal dopamine receptors.
    Jose PA; Raymond JR; Bates MD; Aperia A; Felder RA; Carey RM
    J Am Soc Nephrol; 1992 Feb; 2(8):1265-78. PubMed ID: 1627751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine receptor subtypes in the human pulmonary arterial tree.
    Ricci A; Mignini F; Tomassoni D; Amenta F
    Auton Autacoid Pharmacol; 2006 Oct; 26(4):361-9. PubMed ID: 16968475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral relaxant activity of apomorphine and of a D1 selective receptor agonist on human corpus cavernosum strips.
    d'Emmanuele di Villa Bianca R; Sorrentino R; Roviezzo F; Imbimbo C; Palmieri A; De Dominicis G; Montorsi F; Cirino G; Mirone V
    Int J Impot Res; 2005; 17(2):127-33. PubMed ID: 15549138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.